Form 4: VirnetX CEO Kendall Larsen Acquires 1,000 Shares of Common Stock
SEC Form 4 Filing
VirnetX Holding Corp's President and CEO, Kendall Larsen, recently purchased 1,000 shares of the company's common stock at a price of $4.1435 per share.
Summary
- On May 24, 2024, Kendall Larsen, the President and CEO of VirnetX Holding Corp, acquired 1,000 shares of common stock.
- The purchase price was $4.1435 per share.
- Following the transaction, Larsen directly owns 324,633 shares of VirnetX common stock.
- Larsen also has indirect ownership through his spouse (44,649 shares), The Kathleen Sheehan Revocable Trust dtd 2/5/2009 (30,676 shares), and The K2 Investment Fund LLC (15,000 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase is a positive signal, but it's a relatively small transaction and doesn't provide a definitive outlook on the company's performance.
Positives
- The CEO's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The CEO's stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2/5/2009 | Date of The Kathleen Sheehan Revocable Trust. |
| 05/24/2024 | Date of the transaction where Kendall Larsen acquired 1,000 shares of VirnetX common stock. |
| 05/29/2024 | Date of signature on the SEC Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.